Search details
1.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33420610
2.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Article
in English
| MEDLINE | ID: mdl-34886807
3.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33416977
4.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Article
in English
| MEDLINE | ID: mdl-32013967
5.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Article
in English
| MEDLINE | ID: mdl-31511059
6.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Article
in English
| MEDLINE | ID: mdl-30665378
7.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31200353
8.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29501366
9.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Article
in English
| MEDLINE | ID: mdl-30594171
10.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Article
in English
| MEDLINE | ID: mdl-30572856
11.
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40].
Cancer Lett
; 558: 216061, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36813649
12.
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
J Clin Oncol
; 40(11): 1163-1173, 2022 04 10.
Article
in English
| MEDLINE | ID: mdl-34990291
13.
The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort.
Transl Oncol
; 14(2): 100990, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33338876
14.
Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma.
Front Pharmacol
; 12: 627935, 2021.
Article
in English
| MEDLINE | ID: mdl-34512316
15.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol
; 160: 9-17, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33839205
16.
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 4(12): e2138470, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34928359
17.
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
Laryngoscope
; 131(8): 1798-1804, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33616259
18.
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Ann Transl Med
; 9(7): 532, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33987230
19.
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.
Ther Adv Med Oncol
; 12: 1758835920928214, 2020.
Article
in English
| MEDLINE | ID: mdl-32536983
20.
Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.
Cancer Lett
; 468: 27-40, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31604115